Czasopismo Clinical and Experimental Hepatology 2025

Agnieszka Genowska, Dorota Zarębska-Michaluk, Michał Brzdęk, Piotr Tyszko, Birute Strukcinskiene, Iwona Paradowska-Stankiewicz, Piotr Rzymski, Robert Flisiak

DOI: https://doi.org/10.5114/ceh.2025.151703

Abstract Abstract (PDF)

Thromboelastography-guided assessment of coagulation in decompensated liver cirrhosis for the evaluation of blood component transfusions

Andris Romašovs, Aiga Stāka, Jelena Ivanova, Aldis Puķītis

DOI: https://doi.org/10.5114/ceh.2025.151768

Abstract Abstract (PDF)

Serum ascites albumin gradient in predicting the severity of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids

Anru Zhou, Binlin Da, Wenting Lu, Chuanfu Ding, Chunxiang Wang, Zihao Cai, Qin Yin, Jiangqiang Xiao, Ming Zhang, Junhui Chen, Lei Wang, Feng Zhang, Yuzheng Zhuge

DOI: https://doi.org/10.5114/ceh.2025.151628

Abstract Abstract (PDF)

Clinical characteristics and risk factors of metabolic dysfunction-associated steatotic liver disease in lean patients: results of the Polish Gallstone Surgery Registry

Iwona Gorczyca-Głowacka, Łukasz Nawacki, Magdalena Kołomańska, Robert Mazurkiewicz, Marcin Niżnik, Krzysztof Ratnicki, Małgorzata Czerniak, Piotr Myrcha, Maciej Bękarski, Joao Rocha-Neves, Juliana Pereira-Macedo, Kryspin Mitura, Laura Kacprzak, Małgorzata Pajer, Piotr Richter, Kamil Rapacz, Maciej Sroczyński, Mateusz Szmit, Stanisław Głuszek

DOI: https://doi.org/10.5114/ceh.2025.151805

Abstract Abstract (PDF)

Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients

Inas M. Moaz, Samar E. Ghanem, Fatma O. Khalil, Hossam A. Galbt, Ahmed S. Elbauomy, Shimaa K. Elmahdy, Marwa A. Tahoon

DOI: https://doi.org/10.5114/ceh.2025.151811

Abstract Abstract (PDF)

Platelet aggregation as a thrombotic marker in cirrhotic patients with portal vein thrombosis

Heba M. Abdallah, Fathia Elbassal, Eman M. Saber, Aliaa Sabry, Olfat M. Hendy, Mervat R. Nassar, Suzan M. Al-Morshedy

DOI: https://doi.org/10.5114/ceh.2025.151827

Abstract Abstract (PDF)

Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation

Heresh Rezaei, Akram Jamshidzadeh, Hossein Niknahad, Fatemeh Ghaderi, Omid Farshad, Forouzan Khodaei, Tahereh Golzar, Zahra Honarpishefard, Nazi Dastkhosh, Sepideh Maghami, Kiana Yousefipour, Negar Azarpira, Reza Heidari

DOI: https://doi.org/10.5114/ceh.2025.151865

Abstract Abstract (PDF)

Drug-induced liver injury. Part II: Late complications and hepatotoxicity monitoring

Hepatitis E in the pediatric population: An overlooked disease but a genuine concern?

Metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma: Challenges in clinical practice

To use or not to use: Safety of selected painkillers in patients with chronic liver diseases

Hepatic involvement in major respiratory viral infections

Association between metabolic associated fatty liver disease and HCC risk after SVR in HCV patients: A systematic review and meta-analysis

The burden of viral hepatitis infection and mortality: Findings from a population-based study in Poland over 2009–2023

Thromboelastography-guided assessment of coagulation in decompensated liver cirrhosis for the evaluation of blood component transfusions

Serum ascites albumin gradient in predicting the severity of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids

Clinical characteristics and risk factors of metabolic dysfunction-associated steatotic liver disease in lean patients: results of the Polish Gallstone Surgery Registry

Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients

Platelet aggregation as a thrombotic marker in cirrhotic patients with portal vein thrombosis

Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation

Coverage in

Integrated with

Editorial Policies